Publications by authors named "Shiming Lin"

Claim this Profile
P
Proton Beam Therapy Boosts Outcomes of Atezolizumab/Bevacizumab in Advanced Hepatocellular Carcinoma: A Propensity Score Analysis.
Yuan-Hung Kuo, Wei Teng, Po-Ting Lin, Yen-Hao Chen, Chung-Wei Su, Shi-Ming Lin, Chen-Chun Lin, Chun-Yen Lin

Liver Int· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeted fetal NGS panel reveals genetic conditions in sonographically normal fetuses: Insights from a large cohort study.
Han-Ying Chen, Yi-Ting Wang, Jessica Kang, Yi-Yun Tai, Ti-Jia Yuan, Shin-Yu Lin, Shi-Ming Lin

PLoS One· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TKI plus ICI versus ICI alone in high tumor burden hepatocellular carcinoma: a retrospective cohort study.
Po-Ting Lin, Wei Teng, Wei-Ting Chen, Chung-Wei Su, Yi-Chung Hsieh, Chen-Chun Lin, Chun-Yen Lin, Shi-Ming Lin

J Cancer Res Clin Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Asian Conference on Tumor Ablation Guidelines for Hepatocellular Carcinoma.
Shuichiro Shiina, Ryosuke Tateishi, Joon Il Choi, So Yeon Kim, Zhiqiang Meng, Shi-Ming Lin

Liver Cancer· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Taiwan liver cancer association management consensus guidelines for intermediate-stage hepatocellular carcinoma.
I-Cheng Lee, Hung-Wei Wang, Wei Teng, Tsung-Jung Lin, Chien-Hung Chen, Shi-Ming Lin

Clin Mol Hepatol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply: Revisiting FOXP3 expression and its prognostic implications in hepatocellular carcinoma.
Chien-Hao Huang, Wei-Ting Ku, Tsung-Han Wu, Po-Ting Lin, Wei Teng, Chen-Chun Lin, Shi-Ming Lin, Yung-Chang Lin, Chun-Yen Lin

Hepatology· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Moderate Immune-Related Liver Injury Is a Good Factor in Patients with Hepatoma Under Atezolizumab Plus Bevacizumab.
Tai-Chi Wu, Po-Ting Lin, Wei Teng, Eric Yi-Liang Shen, Chung-Wei Su, Chen-Chun Lin, Shi-Ming Lin, Chun-Yen Lin

Cancers (Basel)· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatocellular carcinoma systemic treatment update: From early to advanced stage.
Wei Teng, Tai-Chi Wu, Shi-Ming Lin

Biomed J· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting de novo purine biosynthesis for tuberculosis treatment.
Dirk A Lamprecht, Richard J Wall, Annelies Leemans, Barry Truebody, Joke Sprangers, Shiming Lin

Nature· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Regorafenib for Hepatocellular Carcinoma in Real-World Practice (REFINE): A Prospective, Observational Study.
Yoon Jun Kim, Philippe Merle, Richard S Finn, Masatoshi Kudo, Heinz-Josef Klümpen, Shi-Ming Lin, Yih-Jyh Lin

Liver Cancer· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor-migrating peripheral Foxp3-high regulatory T cells drive poor prognosis in HCC.
Chien-Hao Huang, Wei-Ting Ku, Jayashri Mahalingam, Cheng-Heng Wu, Tsung-Han Wu, Po-Ting Lin, Chen-Chun Lin, Shi-Ming Lin, Yung-Chang Lin, Chun-Yen Lin

Hepatology· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Consensus Guideline of Ablation for Metastatic Liver Tumors by Taiwan Academy of Tumor Ablation.
Ming Shun Wu, Wei-Yu Kao, Ming-Feng Chiang, Po-Heng Chuang, Shih-Jer Hsu, Chen-Chun Lin, Shi-Ming Lin

Liver Cancer· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Publisher Correction: A robust and interpretable ensemble machine learning model for predicting healthcare insurance fraud.
Zeyu Wang, Xiaofang Chen, Yiwei Wu, Linke Jiang, Shiming Lin

Sci Rep· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination of Hepatic Arterial Infusion Chemotherapy with Tyrosine Kinase Inhibitor Provides Better Survival in Advanced Hepatocellular Carcinoma Patients.
Chung-Wei Liu, Po-Ting Lin, Wei Teng, Wei-Ting Chen, Chung-Wei Su, Chen-Chun Lin, Chun-Yen Lin, Shi-Ming Lin

J Hepatocell Carcinoma· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A robust and interpretable ensemble machine learning model for predicting healthcare insurance fraud.
Zeyu Wang, Xiaofang Chen, Yiwei Wu, Linke Jiang, Shiming Lin

Sci Rep· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Durvalumab with or without bevacizumab with transarterial chemoembolisation in hepatocellular carcinoma (EMERALD-1): a multiregional, randomised, double-blind, placebo-controlled, phase 3 study.
Bruno Sangro, Masatoshi Kudo, Joseph P Erinjeri, Shukui Qin, Zhenggang Ren, Shi-Ming Lin

Lancet· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Outcomes and Histologic Findings of Patients With Hepatocellular Carcinoma With Durable Partial Response or Durable Stable Disease After Receiving Atezolizumab Plus Bevacizumab.
Ying-Chun Shen, Tsung-Hao Liu, Alan Nicholas, Akihiko Soyama, Chang-Tsu Yuan, Po-Ting Lin, Shi-Ming Lin

J Clin Oncol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Visual codon: a user-friendly Python program for viewing and optimizing gene GC content.
Shiming Lin, Fei Xu, Bifang Huang, Li-Li Zhao, Danni Pan, Shiqiang Lin

PeerJ· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Absence of Survival Impact from Hepatitis During Immunotherapy in 193 Patients with Advanced Hepatocellular Carcinoma - An Observational Study from Taiwan.
Chi-Han Lin, Yung-Chia Kuo, Hsuan-Chih Kuo, Ching-Ting Wang, Shi-Ming Lin

J Hepatocell Carcinoma· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes of Post-Immunotherapy Durable Responders of Advanced Hepatocellular Carcinoma- with Emphasis on Locoregional Therapy for Oligoprogression.
Tsung-Hao Liu, San-Chi Chen, Kun-Ming Rau, Li-Chun Lu, Po-Ting Lin, Shi-Ming Lin

Liver Cancer· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management Consensus Guidelines for Hepatocellular Carcinoma: 2023 Update on Surveillance, Diagnosis, Systemic Treatment, and Posttreatment Monitoring by the Taiwan Liver Cancer Association and the Gastroenterological Society of Taiwan.
Wei Teng, Hung-Wei Wang, Shi-Ming Lin,

Liver Cancer· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparing Lenvatinib/Pembrolizumab with Atezolizumab/Bevacizumab in Unresectable Hepatocellular Carcinoma: A Real-World Experience with Propensity Score Matching Analysis.
Yu-Chun Hsu, Po-Ting Lin, Wei Teng, Yi-Chung Hsieh, Wei-Ting Chen, Chen-Chun Lin, Chun-Yen Lin, Shi-Ming Lin

Cancers (Basel)· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Python program to merge Sanger sequences: an update.
Shiming Lin, Bifang Huang, Li-Li Zhao, Fei Xu, Danni Pan, Shiqiang Lin

PeerJ· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimizing cardiovascular image segmentation through integrated hierarchical features and attention mechanisms.
Shijia Liao, Bin Wang, Shiming Lin

Technol Health Care· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
:
: a pan-cancer biomarker and disulfidptosis regulator.
Xing Wang, Hong-Quan Zhu, Shi-Ming Lin, Bao-Ying Xia, Bo Xu

Transl Cancer Res· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis